Cryptotanshinone Induces Cell Death in Lung Cancer by Targeting Aberrant Feedback Loops
Abstract:
Signaling pathways oversee highly efficient cellular mechanisms such as growth, division, and death. These processes are controlled by robust negative feedback loops that inhibit receptor-mediated growth factor pathways. Specifically, the ERK, the AKT, and the S6K feedback loops attenuate signaling via growth factor receptors and other kinase receptors to regulate cell growth. Irregularity in any of these supervised processes can lead to uncontrolled cell proliferation and possibly Cancer. These irregularities primarily occur as mutated genes, and an exhaustive search of the perfect drug combination by performing experiments can be both costly and complex. Hence, in this paper, we model the Lung Cancer pathway as a Modified Boolean Network that incorporates feedback. By simulating this network, we theoretically predict the drug combinations that achieve the desired goal for the majority of mutations. Our theoretical analysis identifies Cryptotanshinone, a traditional Chinese herb derivative, as a potent drug component in the fight against cancer. We validated these theoretical results using multiple wet lab experiments carried out on H2073 and SW900 lung cancer cell lines.
Insights
This study models lung cancer pathways using a Modified Boolean Network to predict effective drug combinations. Cryptotanshinone, a Chinese herb derivative, shows promise in combating cancer by targeting key signaling pathways.
Area of Science:
- Computational biology
- Cancer research
- Systems biology
Background:
- Cellular mechanisms like growth, division, and death are regulated by signaling pathways with negative feedback loops.
- Dysregulation of these pathways, particularly ERK, AKT, and S6K loops, can lead to uncontrolled cell proliferation and cancer.
- Identifying optimal drug combinations for cancer treatment through experimentation is challenging and resource-intensive.
Purpose of the Study:
- To develop a computational model for predicting effective drug combinations against lung cancer.
- To investigate the potential of Cryptotanshinone as a cancer therapeutic agent.
Main Methods:
- Modeling the lung cancer pathway as a Modified Boolean Network incorporating feedback mechanisms.
- Simulating the network to theoretically predict drug combinations targeting common mutations.
- Validating theoretical predictions through in vitro experiments on lung cancer cell lines (H2073 and SW900).
Main Results:
- The Modified Boolean Network simulation identified potential drug combinations for various lung cancer mutations.
- Cryptotanshinone was theoretically predicted as a potent component for cancer treatment.
- Experimental validation confirmed the efficacy of the predicted therapeutic strategies on H2073 and SW900 cell lines.
Conclusions:
- Computational modeling offers a cost-effective approach to predict cancer drug combinations.
- Cryptotanshinone demonstrates significant potential as an anti-cancer agent.
- Integrated computational and experimental approaches can accelerate cancer therapy development.
More Related Videos
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:31The Intrinsic Apoptotic Pathway